$QNTA News : Medolife Rx Announces Results of Comp
Post# of 42087
(Total Views: 78)
Posted On: 01/10/2022 9:45:00 AM
$QNTA News : Medolife Rx Announces Results of Comparative Study of Its Flagship CBD-based Muscle Rub and Competitor Products
BURBANK, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"
, a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), announced today that it has completed a study on its polarized cannabidiol (CBD) muscle rub product, sold under the brand Aelia. The study reports that Aelia products are up to 604.7% stronger than with other non-polarized CBD products currently available on the market included in the test by analyzing the effectiveness of the product in reducing inflammation through the inhibition of cyclooxygenase-2 (COX-2) enzyme activity in the human body.
https://finance.yahoo.com/news/medolife-rx-an...00703.html
BURBANK, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"
, a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), announced today that it has completed a study on its polarized cannabidiol (CBD) muscle rub product, sold under the brand Aelia. The study reports that Aelia products are up to 604.7% stronger than with other non-polarized CBD products currently available on the market included in the test by analyzing the effectiveness of the product in reducing inflammation through the inhibition of cyclooxygenase-2 (COX-2) enzyme activity in the human body. https://finance.yahoo.com/news/medolife-rx-an...00703.html
(0)
(0)Scroll down for more posts ▼